TY  - BOOK
AU  - Samira Abdeljalil Elfassi 
AU  - Dina Hossam Eldin Hassanin , 
AU  - Hany Salah Eldin Hamza , 
AU  - Ramy Riad Fekry , 
TI  - Intravitreal versus posterior subtenon  injection of triamcinolone acetonide for treatment of diabetic macular edema / 
PY  - 2015///
CY  - Cairo : 
PB  - Samira Abdeljalil Elfassi , 
KW  - Diabetic Macular Edema
KW  - Triamcinolone
KW  - Versus posterior subtenon
N1  - Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Ophthalmology; Issued also as CD
N2  - Currently there are many treatment modalities and strategies for DME. Many recent clinical studies show that intravitreal injection of the corticosteroid Triamcinolone Acetonide (TAA) reduce edematous retinal swelling and improve visual acuity in patients with DME. The objective of our prospective comparative study, which included 30 eyes randomized into two groups, was to assess the efficacy and safety of the posterior subtenon injection of Triamcinolone Acetonide  as compared to intravitreal injection for the treatment of diabetic macular edema. The results showed similar improvements in visual acuity and  significant decrease in central macular thickness (CMT) in both groups throughout the 3 months follow up period. However the IOP in the intravitreal injection group was significantly higher than in the posterior  subtenon injection group at 1 and 3 months after injection
UR  - http://172.23.153.220/th.pdf
ER  -